Astera Labs stock saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96. The chip stock sports 95 Relative Strength Rating.
Looking For The Best Stocks To Buy And Watch? Start Here
The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. The top-performing stocks tend to have a 95 or better grade as they launch a significant move so be sure to keep that in mind when looking for the best stocks to buy and watch.
Is Astera Labs Stock A Buy?
Astera Labs stock is not currently near a proper buy point. Look for the stock to form and break out of a new chart pattern.
The stock earns an 82 EPS Rating, meaning its recent quarterly and annual earnings growth is outpacing 82% of all stocks.
Its Accumulation/Distribution Rating of B- shows moderate buying by institutional investors over the last 13 weeks.
Astera Labs Earnings
The semiconductor-based connectivity solutions firm reported a 267% increase in earnings for Q1. Top line growth came in at 144%, down from 179% in the previous quarter.
Astera Labs holds the No. 5 rank among its peers in the Electronics-Semiconductor Fabless industry group. Broadcom is the top-ranked stock within the group. For more industry news, check out "Chip Stocks And Semiconductor Industry News."
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
